The runaway science: a bibliometric analysis of the COVID-19 scientific literature
- PMID: 32701915
- PMCID: PMC8023084
- DOI: 10.23750/abm.v91i9-S.10121
The runaway science: a bibliometric analysis of the COVID-19 scientific literature
Abstract
Background and aim of the work: To reflect on content, trends and quality of scientific publishing on COVID-19. In particular, to report on the systematic screening, quantitative assessment and critical appraisal of the first 10,000 scientific papers published on COVID-19 and to compare how scientific outputs matched identified research priorities and public health needs.
Methods: A comprehensive research strategy was developed to systematically retrieve on a daily basis all studies published on COVID-19. From included studies we extracted: bibliometric parameters, country of studies' implementation and study design. We assigned papers to 25 a priori defined COVID-19-related topics and we described scientific outputs in relation to countries' academic publishing ranking, as well as COVID-19 burden.
Results: 10,000 scientific articles were published on COVID-19 between 20th January and 7th May 2020, accounting for 2.3% of total scientific production over the study period. One third (33%) focused on COVID-19 clinical management, with little adherence to identified research priorities. Over sixty per cent of papers were opinion pieces not reporting original data. Papers were published on 1881 different journals but with half of scientific production included in 8% of journals. The US accounted for one fourth of total scientific production, followed by China (22.2%) and Italy (9%).
Conclusions: Never before in the history of academic publishing such a great volume of research focused on a single topic, this being likely to introduce major changes in the way science is produced and communicated, at the risk of bringing it far from its ultimate aim: informing clinical and public health practice and decision making.
Conflict of interest statement
Each author declares that he or she has no commercial associations (e.g. consultancies, stock ownership, equity interest, patent/licensing arrangement etc.) that might pose a conflict of interest in connection with the submitted article
Figures
Comment in
-
Prospective studies are needed of the neurology and neuropsychiatry of COVID-19: reply.Acta Biomed. 2020 Sep 7;91(4):e2020128. doi: 10.23750/abm.v91i4.10594. Acta Biomed. 2020. PMID: 33525251 Free PMC article.
Similar articles
-
The wave of "opinion articles" in the coverage of COVID-19 in surgical literature.Langenbecks Arch Surg. 2020 Sep;405(6):877-878. doi: 10.1007/s00423-020-01932-w. Epub 2020 Jul 17. Langenbecks Arch Surg. 2020. PMID: 32676739 Free PMC article.
-
The first 10 000 COVID-19 papers in perspective: are we publishing what we should be publishing?Eur J Public Health. 2020 Oct 1;30(5):849-850. doi: 10.1093/eurpub/ckaa170. Eur J Public Health. 2020. PMID: 32818266 Free PMC article. No abstract available.
-
Coronavirus Disease (COVID-19): A Machine Learning Bibliometric Analysis.In Vivo. 2020 Jun;34(3 Suppl):1613-1617. doi: 10.21873/invivo.11951. In Vivo. 2020. PMID: 32503819 Free PMC article. Review.
-
Publishing in pandemic times: A bibliometric analysis of early medical publications on Kawasaki-like disease (MIS-C, PIMS-TS) related to SARS-CoV-2.Arch Pediatr. 2021 Aug;28(6):464-469. doi: 10.1016/j.arcped.2021.05.002. Epub 2021 May 28. Arch Pediatr. 2021. PMID: 34140220
-
The COVID-19 research landscape: Measuring topics and collaborations using scientific literature.Medicine (Baltimore). 2020 Oct 23;99(43):e22849. doi: 10.1097/MD.0000000000022849. Medicine (Baltimore). 2020. PMID: 33120818 Free PMC article.
Cited by
-
Living through and with the global HIV/AIDS pandemic: Distinct 'pandemic practices' and temporalities.Soc Sci Med. 2022 Mar;296:114809. doi: 10.1016/j.socscimed.2022.114809. Epub 2022 Feb 12. Soc Sci Med. 2022. PMID: 35180591 Free PMC article.
-
Stigma, mental illness, and COVID-19 from a frontline clinician perspective: a way to go against the grain?Acta Biomed. 2021 Oct 1;92(S6):e2021442. doi: 10.23750/abm.v92iS6.12235. Acta Biomed. 2021. PMID: 34739466 Free PMC article.
-
The effect of acupoint herbal patching on the quality of life of patients recovering from COVID-19: A protocol for systematic review and meta analysis.Medicine (Baltimore). 2021 May 14;100(19):e25979. doi: 10.1097/MD.0000000000025979. Medicine (Baltimore). 2021. PMID: 34106672 Free PMC article.
-
Characteristics of academic publications, preprints, and registered clinical trials on the COVID-19 pandemic.PLoS One. 2020 Oct 6;15(10):e0240123. doi: 10.1371/journal.pone.0240123. eCollection 2020. PLoS One. 2020. PMID: 33022014 Free PMC article.
-
Publications and retracted articles of COVID-19 pharmacotherapy-related research: A systematic review.Sci Prog. 2021 Apr-Jun;104(2):368504211016936. doi: 10.1177/00368504211016936. Sci Prog. 2021. PMID: 33989091 Free PMC article.
References
-
- The Economist. High-speed science. Available: https://www.economist.com/leaders/2020/05/09/speeding-up-science-during-.... [Accesssed: 17.05.2020]
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials